Novella Pugliese

38PUBLICATIONS
106CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical mycologyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Aug 15, 2026
Janus kinase inhibitors after ruxolitinib failure in myelofibrosis: A systematic review and pooled analysis of phase 3 efficacy and integrated safety across clinical trials and real-world evidence.

|Jun 11, 2026
A dynamic prognostic model for polycythemia vera long-term outcomes in patients treated with ruxolitinib.

|May 12, 2026
Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study.

|Feb 13, 2026
Survival and quality-of-life implications of cytopenia trajectories in ruxolitinib-treated myelofibrosis.

Francesca Palandri, Giovanni Caocci, Elisabetta Abruzzese

|Jan 28, 2026
Targeted Therapy for a Rare PDGFRB-Rearranged Myeloproliferative Neoplasm: A Case Report.

Cosimo Barbato, Vito A Lasorsa, Francesco Grimaldi

|Nov 06, 2025
Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer Centers.

Marco Picardi, Annamaria Vincenzi, Claudia Giordano

Pageof 7

Frequent Collaborators

14 joint publications

Mario Tiribelli

14 joint publications

Massimo Breccia

12 joint publications

Francesca Palandri

12 joint publications

Elisabetta Abruzzese